SAN FRANCISCO
Savonix, a global leader in digital cognitive health testing, is proud to announce the launch of its Japanese website – visitors are invited to explore at Savonix.jp.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201021005024/en/
Savonix.jp
The website explains the science behind Savonix’s brain health platform. It highlights ways the company can provide cognitive health and data insights to support people and companies in Japan to monitor brain health, understand risk factors for developing dementia and take steps to reduce the risk of getting dementia.
“I’m excited that the Savonix website is now available in Japan. Japan faces the world’s highest rate of dementia in a super aging society and we are thrilled to help the people of Japan with resources to better understand dementia and to monitor their brain health to reduce risk,” said Dr. Mylea Charvat, Founder, and CEO of Savonix. “The website also provides another avenue for us to stress the importance of taking cognitive assessments regularly and living a healthy lifestyle to prevent dementia.”
More than 4.6 million people in Japan suffer from some form of dementia, with the total expected to soar to about 7.3 million people by 2025. These numbers underscore the importance of cognitive testing for early detection of impairment. Savonix has always understood that importance – its flagship product, Savonix Mobile available in the app store provides cognitive tests and lifestyle risk assessments for dementia that can be taken on any mobile device and is available in Japan through our partnerships with Fujitsu Connected Technologies Limited and Mitani Sangyo companies.Co, Ltd.
Savonix is no newcomer in the Japanese market – it has partnered with Fujitsu Connected Technologies Limited and Mitani Sangyo companies.Co, Ltd to deliver accessible and accurate cognitive testing to users in the country.
For more information on Savonix, visit savonix.jp.
About Savonix
A global leader in cognitive health, Savonix delivers the only neuropsychology platform in the market. Savonix provides digital cognitive health solutions and empowers healthcare providers, payers, and researchers to evaluate and leverage results to improve health and treatment outcomes. Developed by clinical neuropsychologists and digital health technology experts, the Savonix Cognitive Assessment is an accurate, accessible, and affordable tool for downloading on all mobile devices.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201021005024/en/
CONTACT
Savonix
Reynald Hiole
+1.415.919.7421
rhiole@savonix.com
